NCT03816345 2026-03-18
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Rochester
Children's Oncology Group
Mayo Clinic
Children's Oncology Group
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)